The widow of a lawyer who took his own life, allegedly after taking the generic equivalent of widely prescribed antidepressant drug, Paxil, will not get a chance to undo a federal appeals court’s decision to toss out a federal jury’s findings that GSK, the maker of Paxil, owes her $3 million because it allegedly didn’t push federal regulators hard enough to revise the drug’s warning label.
Recent News About U.S. Supreme Court View More
Pritzker, union say US high court should reject class action attempt vs SEIU over unconstitutional fees
Unions that used a state law which was later declared to be unconstitutional to take millions of dollars from non-union home caregivers who were not employed by the state should not be exposed to the risk of a class action lawsuit to force the union to refund those unconstitutional fees, Illinois’ governor and attorneys for a union said in briefs filed with the U.S. Supreme Court this week.
SCOTUS decision could mean new hearing for widow's suit vs GSK over suicide of lawyer taking generic Paxil
A federal appeals court in Chicago could be tasked with taking another look at its previous decision undoing a jury verdict ordering drug maker GSK to pay $3 million to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of a widely prescribed antidepressant drug.